DrReddy 's has announced its second quarter results. CNBC-TV18's research analyst Sunita Nagpal reviews the numbers.
Earnings Snapshot:
The company's Q2 net profit was up at Rs 292.5 crore (Rs 2.92 billion) from Rs 90.9 crore (Rs 909 million).
Its revenues increased to Rs 1,982.6 crore (Rs 19.82 billion) from Rs 584.7 crore (Rs 5.84 billion).
Its blended margins stood at 42%. The company's international business grew 391% and its core business grew at 41%. Betapharm contributed 20% of revenues and API grew 36%.